Accufix develops an FDA-approved toe joint resurfacing system designed to improve the symptoms of toe arthritis.
Accufix has raised $3.6M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2022.
Accufix's investors include Minnow Ventures.
Accufix is headquartered in West Haven, United States.
Accufix develops an FDA-approved toe joint resurfacing system designed to improve the symptoms of toe arthritis.
Accufix is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Accufix — Funding & Investors." VCBacked, October 3, 2022, https://www.vcbacked.co/company/accufix. Accessed August 13, 2026.
VCBacked. (2022). Accufix — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/accufix
{{cite web |title=Accufix — Funding & Investors |url=https://www.vcbacked.co/company/accufix |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated